|
May 2
|
Adaptive Biotechnologies Shares Surge After Q1 Loss Narrows, Revenue Rises
|
|
May 2
|
Q1 2025 Adaptive Biotechnologies Corp Earnings Call
|
|
May 2
|
Adaptive Biotechnologies Corp (ADPT) Q1 2025 Earnings Call Highlights: Strong MRD Revenue ...
|
|
May 1
|
Adaptive Biotechnologies (ADPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
May 1
|
Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 1
|
Adaptive Biotechnologies: Q1 Earnings Snapshot
|
|
May 1
|
Adaptive Biotechnologies Reports First Quarter 2025 Financial Results
|
|
Mar 11
|
Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma
|
|
Jan 17
|
Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?
|
|
Jan 16
|
Adaptive Biotechnologies (ADPT) Soars 18.0%: Is Further Upside Left in the Stock?
|
|
Jan 2
|
Adaptive Biotechnologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference
|
|
Jan 1
|
Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?
|